EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis

Sabkat Mahmud, Alvira Ajadee, Md Ahad Ali, Md Feroj Ahmed, Reaz Ahmmed, Md Masud Rana, Tasfia Noor, Md Fahim Faysal, Md Hadiul Kabir, Md Nurul Haque Mollah iD

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Sabkat Mahmud und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Drug Repositioning, Transcriptome, Antiviral Agents. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monkeypox (MPOX) virus infection outbreak in Africa in 2022 was initially considered a neglected tropical disease (NTD). Now it is recognized as a global health problem. The recent global spread has emphasized the need for increased attention to combat MPOX. Although there are some vaccines against MPOX, most people worldwide are still not vaccinated due to their unawareness or unavailability. However, so far, there is no approved drug against MPOX yet. Therefore, effective drugs against MPOX are also essential. This study attempted to disclose pathogenic processes and therapeutic strategies of MPOX based on MPOX-associated host key-genes (hKGs). At first, three transcriptomic profile datasets were analyzed, identifying 166 common host differentially expressed genes (hDEGs) between MPOX patients and control groups, comprising 75 upregulated and 91 downregulated hDEGs. Subsequently, six top-ranked host key genes (hKGs): ALB, HSP90AA1, CDH1, PTPRC, IGF1, and ABL1, were identified as potential MPOX-causing genes through protein-protein interaction (PPI) network analysis. Functional enrichment analysis of these hKGs revealed critical pathogenic processes of MPOX infection, including biological processes, molecular functions, cellular components, and KEGG pathways. Regulatory network analysis involving transcription factors and miRNAs provided further insights into disease mechanisms. Based on molecular docking analysis, five top-ranked drug molecules Tecovirimat, Beclabuvir, Maraviroc, Raltegravir, and Brincidofovir were identified as potential repurposable therapeutics against MPOX. ADME/T and drug-likeness evaluations confirmed favorable pharmacokinetic properties for these candidates. Additionally, 100 ns molecular dynamics (MD) simulations of the top three complexes (ALB-Tecovirimat, CDH1-Maraviroc, and PPARG-Beclabuvir) demonstrated strong binding stability, supported by RMSD, RMSF, and MM-GBSA results. Therefore, the results provided in this study might be potential resources for diagnosis and therapies of MPOX patients. However, the findings require experimental validation in wet lab for further confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mpox, MonkeypoxDrug RepositioningTranscriptomeAntiviral AgentsMonkeypox virusHumansGene Expression ProfilingMolecular Docking SimulationProtein Interaction Maps

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Bioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh.
  • Tulane Center for Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, United States of America.
  • Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, Texas, United States of America.
  • Department of Biochemistry & Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh.
  • Department of Statistics and Data Science, University of Barishal, Barishal, Bangladesh.
  • Department of Computer Science and Engineering, Rajshahi University of Engineering and Technology, Rajshahi, Bangladesh.

ORCID-Profile: Md Nurul Haque Mollah

Zitieren

APA

Mahmud, S., Ajadee, A., Ali, M. A., Ahmed, M. F., Ahmmed, R., Rana, M. M., Noor, T., Faysal, M. F., Kabir, M. H., & Mollah, M. N. H. (2026). Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014797

Vancouver

Mahmud S, Ajadee A, Ali MA, Ahmed MF, Ahmmed R, Rana MM, et al. Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014797

BibTeX
@article{Mahmud2026,
  author = {Mahmud, Sabkat and Ajadee, Alvira and Ali, Md Ahad and Ahmed, Md Feroj and Ahmmed, Reaz and Rana, Md Masud and Noor, Tasfia and Faysal, Md Fahim and Kabir, Md Hadiul and Mollah, Md Nurul Haque},
  title = {Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014797}
}
Kostenlos starten →